Alector (ALEC) Net Margin (2018 - 2026)

Alector (ALEC) reported Net Margin of 2192.16% for Q1 2026, down 109061.0% year-over-year from N/an in Q1 2025, and down 266.88% quarter-over-quarter from 597.51% in Q4 2025.

Alector (ALEC) Net Margin (2018 - 2026) Analysis & Trends

Alector (ALEC) has 9 years of Net Margin data on file, last reported at 2192.16% in Q1 2026.

  • Net Margin for Q1 2026 came in at 2192.16%, down 109061.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 680.83% (down 54124.0% YoY), and the FY2025 annual result was 679.16%, down 56090.0% from the prior year.
  • Net Margin fell to 2192.16% in Q1 2026 per ALEC's latest filing, from 597.51% in the prior quarter.
  • Over five years, Net Margin peaked at 12.38% in Q2 2022 and troughed at 2192.16% in Q1 2026.
  • A 5-year average of 468.81% and a median of 277.1% in 2023 frame the typical range for Net Margin.
  • The sharpest annual moves came in 2022 and 2026: Net Margin jumped 108706 bps in 2022, then sank 109061 bps in 2026.
  • A 5-year view of Net Margin shows it stood at 355.84% in 2022, then climbed by 25 bps to 265.96% in 2023, then surged by 99 bps to 3.59% in 2024, then sank by 16554 bps to 597.51% in 2025, then plunged by 267 bps to 2192.16% in 2026.
  • Business Quant data shows ALEC's Net Margin at 2192.16% in Q1 2026, 597.51% in Q4 2025, and 1063.4% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.82%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 34.53%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Alector 193.53 Mn -12.98 Mn - -2,192.16%

Historic Data

Download Data
DateValue
Mar 31, 2026 -2,192.16%
Dec 31, 2025 -597.51%
Sep 30, 2025 -1,063.40%
Jun 30, 2025 -387.66%
Mar 31, 2025 -1,101.55%
Dec 31, 2024 -3.59%
Sep 30, 2024 -275.19%
Jun 30, 2024 -256.42%
Mar 31, 2024 -227.01%
Dec 31, 2023 -265.96%
Sep 30, 2023 -488.25%
Jun 30, 2023 2.45%
Mar 31, 2023 -277.10%
Dec 31, 2022 -355.84%
Sep 30, 2022 -310.72%
Jun 30, 2022 12.38%
Mar 31, 2022 -182.30%
Dec 31, 2021 -397.37%
Sep 30, 2021 69.40%
Jun 30, 2021 -839.63%